1. Home
  2. SLNO vs PATK Comparison

SLNO vs PATK Comparison

Compare SLNO & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • PATK
  • Stock Information
  • Founded
  • SLNO 1999
  • PATK 1959
  • Country
  • SLNO United States
  • PATK United States
  • Employees
  • SLNO N/A
  • PATK N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PATK Auto Parts:O.E.M.
  • Sector
  • SLNO Health Care
  • PATK Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • PATK Nasdaq
  • Market Cap
  • SLNO 3.2B
  • PATK 2.7B
  • IPO Year
  • SLNO 2014
  • PATK N/A
  • Fundamental
  • Price
  • SLNO $73.35
  • PATK $85.86
  • Analyst Decision
  • SLNO Strong Buy
  • PATK Buy
  • Analyst Count
  • SLNO 9
  • PATK 10
  • Target Price
  • SLNO $103.33
  • PATK $101.53
  • AVG Volume (30 Days)
  • SLNO 744.8K
  • PATK 276.4K
  • Earning Date
  • SLNO 05-07-2025
  • PATK 05-01-2025
  • Dividend Yield
  • SLNO N/A
  • PATK 2.27%
  • EPS Growth
  • SLNO N/A
  • PATK N/A
  • EPS
  • SLNO N/A
  • PATK 4.16
  • Revenue
  • SLNO N/A
  • PATK $3,785,611,000.00
  • Revenue This Year
  • SLNO N/A
  • PATK $3.48
  • Revenue Next Year
  • SLNO N/A
  • PATK $5.93
  • P/E Ratio
  • SLNO N/A
  • PATK $20.63
  • Revenue Growth
  • SLNO N/A
  • PATK 8.12
  • 52 Week Low
  • SLNO $36.93
  • PATK $67.72
  • 52 Week High
  • SLNO $80.99
  • PATK $98.90
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 49.78
  • PATK 51.99
  • Support Level
  • SLNO $72.29
  • PATK $83.23
  • Resistance Level
  • SLNO $78.32
  • PATK $89.44
  • Average True Range (ATR)
  • SLNO 2.74
  • PATK 2.19
  • MACD
  • SLNO -0.57
  • PATK -0.14
  • Stochastic Oscillator
  • SLNO 27.11
  • PATK 39.02

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: